DOCSLIB.ORG

Sporaefaciens Musculi Gen. Nov., Sp. Nov., a Novel Bacterium Isolated

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Sporaefaciens Musculi Gen. Nov., Sp. Nov., a Novel Bacterium Isolated bioRxiv preprint doi: https://doi.org/10.1101/2019.12.21.885665; this version posted December 27, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC 4.0 International license. 1 Taxonomic description 2 Sporaefaciens musculi gen. nov., sp. nov., a novel bacterium 3 isolated from the caecum of an obese mouse 4 Torben Sølbeck Rasmussen1*, Theresa Streidl2, Thomas C.A. Hitch2, Esther Wortmann2, 1 4 1 2,3 5 Paulina Deptula , Michael Hansen , Dennis Sandris Nielsen , Thomas Clavel , Finn Kvist 6 Vogensen1* 7 1 Section of Microbiology and Fermentation, Dept. of Food Science, Faculty of Science, University of 8 Copenhagen, Denmark 9 2 Functional Microbiome Research Group, Institute of Medical Microbiology, RWTH University Hospital, 10 Aachen, Germany 11 3 ZIEL Core Facility Microbiome, Technical University of Munich, Freising, Germany 12 4 Center for Advanced Bioimaging, Department of Plant and Environmental Sciences, University of 13 Copenhagen, Frederiksberg, Denmark 14 Keywords: Firmicutes, Lachnospiraceae, mouse faeces, diet-induced obesity, spore-forming, 15 succinate, acetate 16 *Correspondence: Torben S. Rasmussen – [email protected] & Finn K. Vogensen - 17 [email protected] 18 Abbreviations: WCA, Wilkens-Chalgren-Anaerobe; GAM, Gifu Anaerobic Medium; RT, Room 19 Temperature; ONT, Oxford Nanopore Technologies; ANI, Average Nucleotide Identity; SEM, 20 Scanning Electron Microscopy; SIM, Sulphide Indole Motility; HPLC-RI, High Performance Liquid 21 Chromatography – Refractive Index; SCFA, Short Chain Fatty Acid; CRISPR, Clustered Regularly 22 Interspaced Short Palindromic Repeats; VLPs, virus-like-particles; TUM, Technical University of 23 Munich; UPCH, University of Copenhagen; POCP, Percentage of conserved proteins. 24 Repositories: The GenBank accession number for the 16S rRNA gene sequence of strain WCA- 25 9-b2T is MN756014, and the accession number for the genome assembly is PRJNA592877. Raw 26 sequencing Illumina NextSeq (PRJEB35655) and ONT MinION (PRJEB35656) data can be 27 accessed at EMBL-EBI. 28 Four supplementary figures are available with the online version of this article. Page 1 of 17 bioRxiv preprint doi: https://doi.org/10.1101/2019.12.21.885665; this version posted December 27, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC 4.0 International license. 29 Abstract 30 A bacterial strain, designated WCA-9-b2, was isolated from the caecal content of an 18-week-old 31 obese C57BL/6NTac male mouse. According to phenotypic analyses, the isolate is rod-shaped, 32 Gram-positive, strictly anaerobic, spore-forming and non-motile under the conditions tested. 33 Bacterial colonies were irregular and non-pigmented. Analysis of the 16S rRNA gene indicated that 34 the isolate belonged to the family Lachnospiraceae with Clostridium scindens ATTC 35704 (94.9% 35 sequence identity) and Dorea formicigenerans ATCC 27755 (94.8%) being the closest relatives. 36 Whole genome sequencing showed average nucleotide identity (ANI) ranging from 69.80–74.23% 37 and percentage of conserved proteins (POCP) values < 50% against the nine closest relatives. The 38 genome-based G+C content of genomic DNA was 44.4%. The predominant metabolic end products 39 of glucose fermentation were acetate and succinate. Based on these data, we propose that strain 40 WCA-9-b2 represents a novel species within a novel genus, for which the name Sporaefaciens 41 musculi gen. nov., sp. nov. is proposed. The type strain is WCA-9-b2T (=DSM 106039T = CCUG 42 pending IDT). 43 Page 2 of 17 bioRxiv preprint doi: https://doi.org/10.1101/2019.12.21.885665; this version posted December 27, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC 4.0 International license. 44 Introduction 45 The mammalian gut is inhabited by a high diversity of strictly anaerobic bacteria predominated by 46 Gram-positive species from the phylum Firmicutes [1], of which many have not yet been cultured. 47 Metagenome sequencing has been an efficient tool to perform in silico characterisation of the 48 unculturable gut bacteria [2], although metagenome sequencing often misses spore-forming 49 bacteria due to the difficulty of DNA extraction from the robust structure of the spores [3]. As the 50 mammalian gut microbiota (GM) influences host health [4–6], combining in silico characterisation 51 of gut bacteria with culturing novel isolates in vitro opens new research avenues by investigating 52 their functional properties. A large diversity of bacteria belonging to the class Clostridia contribute 53 in maintaining gut health, amongst other through the production of short chain fatty acids (SCFAs) 54 [7, 8]. Especially, butyrate has been associated with beneficial health effects [7], even though 55 many butyrate producers are dependent on cross-feeding from other bacteria producing 56 intermediate products such as acetate or lactate [9]. Whereas succinate, an intermediate product 57 of propionate, is a double-edge sword that in some conditions sustain the stability of the GM 58 component by cross-feeding, whilst in other conditions elevates the pathogenic potential of 59 infectious bacteria such as Clostridioides difficile or Clostridium rodentium. In the current study we 60 report the cultivation and detailed characterisation of a spore-forming, succinate and acetate 61 producing bacterial strain WCA-9-b2T isolated from the gut of an obese male mouse, which we 62 propose represents a novel genus within family Lachnospiraceae, phylum Firmicutes. 63 Isolation and ecology 64 Strain WCA-9-b2T originated from the caecum of a C57BL/6NTac mouse fed a high-fat diet (HF, 65 Research Diets D12492, USA) ad libitum for 13 weeks as part of a previously published study [10]. 66 The initial isolation of strain WCA-9-b2 took place at the ZIEL Core Facility Microbiome of the 67 Technical University of Munich (TUM), Germany. Downstream analyses were conducted at the 68 University of Copenhagen (UCPH), Denmark. Anaerobic handling and agar plate incubation during 69 isolation at TUM was performed in an anaerobic chamber (VA500 workstation, Don Whitley 70 Scientific) containing an atmosphere of 90 % (v/v) N2 and 10 % H2 a at a temperature of 37°C and 71 a humidity of 75 %. All materials were brought into the anaerobic chamber at least 24 hours before 72 use to ensure anaerobic conditions. Liquid and solid media were autoclaved and contained 0.02% 73 1,4-Dithiothreitol (Sigma, cat. No. DTT-RO) and 0.05% L-cysteine (Sigma, cat. no. 168149) as 74 reducing agents and 1 mg/L resazurin as a redox potential indicator. Broth media were heated 75 prior to flushing with 100% N2 by an anaerobic gassing unit (AGU, QCAL Messtechnik GmbH) for Page 3 of 17 bioRxiv preprint doi: https://doi.org/10.1101/2019.12.21.885665; this version posted December 27, 2019. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC 4.0 International license. 76 at least 3 min. pr. 10 mL. Agar media in Petri dishes contained 1.5% agar (Oxoid™, cat. no. 77 LP0011). Incubations took place at 37°C unless otherwise stated. 78 Strain WCA-9-b2T was isolated on Wilkens-Chalgren-Anaerobe agar (WCA, Sigma, cat. no. 79 W1886) supplemented with 0.1% bile salt (WCA-BS) (sodium taurocholate hydrate, Sigma, cat. no. 80 86339) to enhance spore germination. Approx. ~20 mg thawed caecum content was transferred to 81 a 0.20 µm sterile filtered 1:1 mixture of PBS (NaCl 137mM, KCl 2.7 mM, Na2HPO4 10 mM, KH2PO4 82 1.8mM) and 70% ethanol to kill vegetative cells. The suspension was incubated at RT (room 83 temperature) under aerobic conditions for four hours and vortexed every 30 min., followed by 3x 84 centrifugation (11000 x g, 5 min.) and resuspension in aerobic PBS. Ten-fold serial dilutions were 85 prepared with anoxic PBS containing 0.02 % peptone (Sigma, cat. no. 91249). Each dilution (10 µl) 86 was deposited on WCA-BS agar and immediately tilted for vertical migration on the plate, followed 87 by incubation at 37°C for 4 days. Bacterial colonies from a representative area were picked and 88 further re-streaked on WCA agar 3x to obtain pure cultures. WCA-9-b2T was deposited at the 89 Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH (DSM 106039) and the Culture 90 Collection University of Gothenburg (CCUG pending IDT). Liquid nitrogen was used to snap-freeze 91 cryo-aliquots (pivotal for survival of the strain), i.e., cultures diluted 1:1 in 50% glycerol, and then 92 stored at -80°C. 93 Gifu Anaerobic Medium (GAM, HyServe, cat. no. 5422) was used for downstream analyses, since 94 strain WCA-9-b2T showed improved growth in GAM vs. WCA. GAM agar was supplemented with 2 95 mL/L titanium(III) chloride (GAM-TC) (Sigma, cat. no. 1107890001) solution [11, 12] as an 96 additional oxygen scavenger to obtain clear colonies on Petri dishes. The anaerobic handling of 97 downstream analyses at UCPH was performed in another anaerobic chamber (Model AALC, Coy 98 Laboratory Products) containing ~93% (v/v) N2, ~2% H2, ~5% CO2 and an atmosphere kept at RT. 99 Agar plates were incubated at 37C in an anaerobic jar (Cat. No. HP0011A, Thermo Scientific) 100 containing an anaerobic sachet (Cat.
Load more

Recommended publications
  • Gut Microbiota and Inflammation
    Nutrients 2011, 3, 637-682; doi:10.3390/nu3060637 OPEN ACCESS nutrients ISSN 2072-6643 www.mdpi.com/journal/nutrients Review Gut Microbiota and Inflammation Asa Hakansson and Goran Molin * Food Hygiene, Division of Applied Nutrition, Department of Food Technology, Engineering and Nutrition, Lund University, PO Box 124, SE-22100 Lund, Sweden; E-Mail: [email protected] * Author to whom correspondence should be addressed; E-Mail: [email protected]; Tel.: +46-46-222-8327; Fax: +46-46-222-4532. Received: 15 April 2011; in revised form: 19 May 2011 / Accepted: 24 May 2011 / Published: 3 June 2011 Abstract: Systemic and local inflammation in relation to the resident microbiota of the human gastro-intestinal (GI) tract and administration of probiotics are the main themes of the present review. The dominating taxa of the human GI tract and their potential for aggravating or suppressing inflammation are described. The review focuses on human trials with probiotics and does not include in vitro studies and animal experimental models. The applications of probiotics considered are systemic immune-modulation, the metabolic syndrome, liver injury, inflammatory bowel disease, colorectal cancer and radiation-induced enteritis. When the major genomic differences between different types of probiotics are taken into account, it is to be expected that the human body can respond differently to the different species and strains of probiotics. This fact is often neglected in discussions of the outcome of clinical trials with probiotics. Keywords: probiotics; inflammation; gut microbiota 1. Inflammation Inflammation is a defence reaction of the body against injury. The word inflammation originates from the Latin word ―inflammatio‖ which means fire, and traditionally inflammation is characterised by redness, swelling, pain, heat and impaired body functions.
    [Show full text]
  • WO 2018/064165 A2 (.Pdf)
    (12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (10) International Publication Number (43) International Publication Date WO 2018/064165 A2 05 April 2018 (05.04.2018) W !P O PCT (51) International Patent Classification: Published: A61K 35/74 (20 15.0 1) C12N 1/21 (2006 .01) — without international search report and to be republished (21) International Application Number: upon receipt of that report (Rule 48.2(g)) PCT/US2017/053717 — with sequence listing part of description (Rule 5.2(a)) (22) International Filing Date: 27 September 2017 (27.09.2017) (25) Filing Language: English (26) Publication Langi English (30) Priority Data: 62/400,372 27 September 2016 (27.09.2016) US 62/508,885 19 May 2017 (19.05.2017) US 62/557,566 12 September 2017 (12.09.2017) US (71) Applicant: BOARD OF REGENTS, THE UNIVERSI¬ TY OF TEXAS SYSTEM [US/US]; 210 West 7th St., Austin, TX 78701 (US). (72) Inventors: WARGO, Jennifer; 1814 Bissonnet St., Hous ton, TX 77005 (US). GOPALAKRISHNAN, Vanch- eswaran; 7900 Cambridge, Apt. 10-lb, Houston, TX 77054 (US). (74) Agent: BYRD, Marshall, P.; Parker Highlander PLLC, 1120 S. Capital Of Texas Highway, Bldg. One, Suite 200, Austin, TX 78746 (US). (81) Designated States (unless otherwise indicated, for every kind of national protection available): AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JO, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
    [Show full text]
  • Diarrhea Predominant-Irritable Bowel Syndrome (IBS-D): Effects of Different Nutritional Patterns on Intestinal Dysbiosis and Symptoms
    nutrients Review Diarrhea Predominant-Irritable Bowel Syndrome (IBS-D): Effects of Different Nutritional Patterns on Intestinal Dysbiosis and Symptoms Annamaria Altomare 1,2 , Claudia Di Rosa 2,*, Elena Imperia 2, Sara Emerenziani 1, Michele Cicala 1 and Michele Pier Luca Guarino 1 1 Gastroenterology Unit, Campus Bio-Medico University of Rome, Via Álvaro del Portillo 21, 00128 Rome, Italy; [email protected] (A.A.); [email protected] (S.E.); [email protected] (M.C.); [email protected] (M.P.L.G.) 2 Unit of Food Science and Human Nutrition, Campus Bio-Medico University of Rome, Via Álvaro del Portillo 21, 00128 Rome, Italy; [email protected] * Correspondence: [email protected] Abstract: Irritable Bowel Syndrome (IBS) is a chronic functional gastrointestinal disorder charac- terized by abdominal pain associated with defecation or a change in bowel habits. Gut microbiota, which acts as a real organ with well-defined functions, is in a mutualistic relationship with the host, harvesting additional energy and nutrients from the diet and protecting the host from pathogens; specific alterations in its composition seem to play a crucial role in IBS pathophysiology. It is well known that diet can significantly modulate the intestinal microbiota profile but it is less known how different nutritional approach effective in IBS patients, such as the low-FODMAP diet, could be Citation: Altomare, A.; Di Rosa, C.; responsible of intestinal microbiota changes, thus influencing the presence of gastrointestinal (GI) Imperia, E.; Emerenziani, S.; Cicala, symptoms. The aim of this review was to explore the effects of different nutritional protocols (e.g., M.; Guarino, M.P.L.
    [Show full text]
  • Specific Substrate-Driven Changes in Human Faecal Microbiota Composition Contrast with Functional Redundancy in Short-Chain Fatty Acid Production
    The ISME Journal (2018) 12, 610–622 © 2018 International Society for Microbial Ecology All rights reserved 1751-7362/18 www.nature.com/ismej ORIGINAL ARTICLE Specific substrate-driven changes in human faecal microbiota composition contrast with functional redundancy in short-chain fatty acid production Nicole Reichardt1,2, Maren Vollmer1, Grietje Holtrop3, Freda M Farquharson1, Daniel Wefers4, Mirko Bunzel4, Sylvia H Duncan1, Janice E Drew1, Lynda M Williams1, Graeme Milligan2, Thomas Preston5, Douglas Morrison5, Harry J Flint1 and Petra Louis1 1The Rowett Institute, University of Aberdeen, Foresterhill, Aberdeen, UK; 2Institute of Molecular, Cell and Systems Biology, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, UK; 3Biomathematics and Statistics Scotland, Foresterhill, Aberdeen, UK; 4Department of Food Chemistry and Phytochemistry, Karlsruhe Institute of Technology (KIT), Adenauerring 20A, Karlsruhe, Germany and 5Scottish Universities Environmental Research Centre, University of Glasgow, Rankine Avenue, East Kilbride, UK The diet provides carbohydrates that are non-digestible in the upper gut and are major carbon and energy sources for the microbial community in the lower intestine, supporting a complex metabolic network. Fermentation produces the short-chain fatty acids (SCFAs) acetate, propionate and butyrate, which have health-promoting effects for the human host. Here we investigated microbial community changes and SCFA production during in vitro batch incubations of 15 different non-digestible carbohydrates, at two initial pH values with faecal microbiota from three different human donors. To investigate temporal stability and reproducibility, a further experiment was performed 1 year later with four of the carbohydrates. The lower pH (5.5) led to higher butyrate and the higher pH (6.5) to more propionate production.
    [Show full text]
  • Nor Hawani Salikin
    Characterisation of a novel antinematode agent produced by the marine epiphytic bacterium Pseudoalteromonas tunicata and its impact on Caenorhabditis elegans Nor Hawani Salikin A thesis in fulfilment of the requirements for the degree of Doctor of Philosophy School of Biological, Earth and Environmental Sciences Faculty of Science August 2020 Thesis/Dissertation Sheet Surname/Family Name : Salikin Given Name/s : Nor Hawani Abbreviation for degree as give in the University : Ph.D. calendar Faculty : UNSW Faculty of Science School : School of Biological, Earth and Environmental Sciences Characterisation of a novel antinematode agent produced Thesis Title : by the marine epiphytic bacterium Pseudoalteromonas tunicata and its impact on Caenorhabditis elegans Abstract 350 words maximum: (PLEASE TYPE) Drug resistance among parasitic nematodes has resulted in an urgent need for the development of new therapies. However, the high re-discovery rate of antinematode compounds from terrestrial environments necessitates a new repository for future drug research. Marine epiphytic bacteria are hypothesised to produce nematicidal compounds as a defence against bacterivorous predators, thus representing a promising, yet underexplored source for antinematode drug discovery. The marine epiphytic bacterium Pseudoalteromonas tunicata is known to produce a number of bioactive compounds. Screening genomic libraries of P. tunicata against the nematode Caenorhabditis elegans identified a clone (HG8) showing fast-killing activity. However, the molecular, chemical and biological properties of HG8 remain undetermined. A novel Nematode killing protein-1 (Nkp-1) encoded by an uncharacterised gene of HG8 annotated as hp1 was successfully discovered through this project. The Nkp-1 toxicity appears to be nematode-specific, with the protein being highly toxic to nematode larvae but having no impact on nematode eggs.
    [Show full text]
  • Outline Release 7 7C
    Garrity, et. al., March 6, 2007 Taxonomic Outline of the Bacteria and Archaea, Release 7.7 March 6, 2007. Part 7 – The Bacteria: Phylum “Firmicutes”: Class “Clostridia” George M. Garrity, Timothy G. Lilburn, James R. Cole, Scott H. Harrison, Jean Euzéby, and Brian J. Tindall F Phylum Firmicutes AL N4Lid DOI: 10.1601/nm.3874 Class "Clostridia" N4Lid DOI: 10.1601/nm.3875 71 Order Clostridiales AL Prévot 1953. N4Lid DOI: 10.1601/nm.3876 Family Clostridiaceae AL Pribram 1933. N4Lid DOI: 10.1601/nm.3877 Genus Clostridium AL Prazmowski 1880. GOLD ID: Gi00163. GCAT ID: 000971_GCAT. Entrez genome id: 80. Sequenced strain: BC1 is from a non-type strain. Genome sequencing is incomplete. Number of genomes of this species sequenced 6 (GOLD) 6 (NCBI). N4Lid DOI: 10.1601/nm.3878 Clostridium butyricum AL Prazmowski 1880. Source of type material recommended for DOE sponsored genome sequencing by the JGI: ATCC 19398. High-quality 16S rRNA sequence S000436450 (RDP), M59085 (Genbank). N4Lid DOI: 10.1601/nm.3879 Clostridium aceticum VP (ex Wieringa 1940) Gottschalk and Braun 1981. Source of type material recommended for DOE sponsored genome sequencing by the JGI: ATCC 35044. High-quality 16S rRNA sequence S000016027 (RDP), Y18183 (Genbank). N4Lid DOI: 10.1601/nm.3881 Clostridium acetireducens VP Örlygsson et al. 1996. Source of type material recommended for DOE sponsored genome sequencing by the JGI: DSM 10703. High-quality 16S rRNA sequence S000004716 (RDP), X79862 (Genbank). N4Lid DOI: 10.1601/nm.3882 Clostridium acetobutylicum AL McCoy et al. 1926. Source of type material recommended for DOE sponsored genome sequencing by the JGI: ATCC 824.
    [Show full text]
  • Meta Analysis of Microbiome Studies Identifies Shared and Disease
    bioRxiv preprint doi: https://doi.org/10.1101/134031; this version posted May 8, 2017. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY-NC 4.0 International license. Meta analysis of microbiome studies identifies shared and disease-specific patterns Claire Duvallet1,2, Sean Gibbons1,2,3, Thomas Gurry1,2,3, Rafael Irizarry4,5, and Eric Alm1,2,3,* 1Department of Biological Engineering, MIT 2Center for Microbiome Informatics and Therapeutics 3The Broad Institute of MIT and Harvard 4Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute 5Department of Biostatistics, Harvard T.H. Chan School of Public Health *Corresponding author, [email protected] Contents 1 Abstract2 2 Introduction3 3 Results4 3.1 Most disease states show altered microbiomes ........... 5 3.2 Loss of beneficial microbes or enrichment of pathogens? . 5 3.3 A core set of microbes associated with health and disease . 7 3.4 Comparing studies within and across diseases separates signal from noise ............................... 9 4 Conclusion 10 5 Methods 12 5.1 Dataset collection ........................... 12 5.2 16S processing ............................ 12 5.3 Statistical analyses .......................... 13 5.4 Microbiome community analyses . 13 5.5 Code and data availability ...................... 13 6 Table and Figures 14 1 bioRxiv preprint doi: https://doi.org/10.1101/134031; this version posted May 8, 2017. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity.
    [Show full text]
  • Depression and Microbiome—Study on the Relation and Contiguity Between Dogs and Humans
    applied sciences Article Depression and Microbiome—Study on the Relation and Contiguity between Dogs and Humans Elisabetta Mondo 1,*, Alessandra De Cesare 1, Gerardo Manfreda 2, Claudia Sala 3 , Giuseppe Cascio 1, Pier Attilio Accorsi 1, Giovanna Marliani 1 and Massimo Cocchi 1 1 Department of Veterinary Medical Science, University of Bologna, Via Tolara di Sopra 50, 40064 Ozzano Emilia, Italy; [email protected] (A.D.C.); [email protected] (G.C.); [email protected] (P.A.A.); [email protected] (G.M.); [email protected] (M.C.) 2 Department of Agricultural and Food Sciences, University of Bologna, Via del Florio 2, 40064 Ozzano Emilia, Italy; [email protected] 3 Department of Physics and Astronomy, Alma Mater Studiorum, University of Bologna, 40126 Bologna, Italy; [email protected] * Correspondence: [email protected]; Tel.: +39-051-209-7329 Received: 22 November 2019; Accepted: 7 January 2020; Published: 13 January 2020 Abstract: Behavioral studies demonstrate that not only humans, but all other animals including dogs, can suffer from depression. A quantitative molecular evaluation of fatty acids in human and animal platelets has already evidenced similarities between people suffering from depression and German Shepherds, suggesting that domestication has led dogs to be similar to humans. In order to verify whether humans and dogs suffering from similar pathologies also share similar microorganisms at the intestinal level, in this study the gut-microbiota composition of 12 German Shepherds was compared to that of 15 dogs belonging to mixed breeds which do not suffer from depression. Moreover, the relation between the microbiota of the German Shepherd’s group and that of patients with depression has been investigated.
    [Show full text]
  • Rebuilding the Gut Microbiota Ecosystem
    International Journal of Environmental Research and Public Health Review Rebuilding the Gut Microbiota Ecosystem Antonella Gagliardi, Valentina Totino, Fatima Cacciotti, Valerio Iebba, Bruna Neroni, Giulia Bonfiglio, Maria Trancassini, Claudio Passariello ID , Fabrizio Pantanella and Serena Schippa * Department of Public Health and Infectious Diseases, Section of Microbiology, Sapienza University of Rome, Rome 00185, Italy; [email protected] (A.G.); [email protected] (V.T.); [email protected] (F.C.); [email protected] (V.I.); [email protected] (B.N.); giulia.bonfi[email protected] (G.B.); [email protected] (M.T.); [email protected] (C.P.); [email protected] (F.P.) * Correspondence: [email protected]; Tel.: +39-339-115-2753 Received: 19 June 2018; Accepted: 4 August 2018; Published: 7 August 2018 Abstract: A microbial ecosystem in which bacteria no longer live in a mutualistic association is called dysbiotic. Gut microbiota dysbiosis is a condition related with the pathogenesis of intestinal illnesses (irritable bowel syndrome, celiac disease, and inflammatory bowel disease) and extra-intestinal illnesses (obesity, metabolic disorder, cardiovascular syndrome, allergy, and asthma). Dysbiosis status has been related to various important pathologies, and many therapeutic strategies aimed at restoring the balance of the intestinal ecosystem have been implemented. These strategies include the administration of probiotics, prebiotics, and synbiotics; phage therapy; fecal transplantation; bacterial consortium transplantation; and a still poorly investigated approach based on predatory bacteria. This review discusses the various aspects of these strategies to counteract intestinal dysbiosis. Keywords: gut microbiota; eubiosis; dysbiosis; therapeutic strategy 1. Introduction Bacteria (bacteriome), fungi (mycome) [1], and viruses (virome) [2] live together in a harmonic and dynamic equilibrium in the intestinal tract.
    [Show full text]
  • Autism Spectrum Disorder (ASD) with and Without Mental Regression Is Associated with Changes in the Fecal Microbiota
    Article Autism Spectrum Disorder (ASD) with and without Mental Regression is Associated with Changes in the Fecal Microbiota Julio Plaza-Díaz 1,2,3,†, Antonio Gómez-Fernández 4,†, Natalia Chueca 3, María José de la Torre-Aguilar 4, Ángel Gil 1,2,3,5, Juan Luis Perez-Navero 4,*, Katherine Flores-Rojas 4,5, Pilar Martín-Borreguero 6, Patricio Solis-Urra 7,8, Francisco Javier Ruiz-Ojeda 9, Federico Garcia 3 and Mercedes Gil-Campos 4,5 1 Department of Biochemistry and Molecular Biology II, School of Pharmacy, University of Granada, 18071 Granada, Spain; [email protected] (J.P.-D.); [email protected] (Á.G.) 2 Institute of Nutrition and Food Technology “José Mataix”, Center of Biomedical Research, University of Granada, 18016 Armilla, Granada, Spain 3 Instituto de Investigación Biosanitaria IBS.GRANADA, Complejo Hospitalario Universitario de Granada, 18014 Granada, Spain; [email protected] (N.C.); [email protected] (F.G.) 4 Pediatric Research and Metabolism Unit, Reina Sofia University Hospital, Maimónides Institute for Biomedical Research of Córdoba (IMIBIC), University of Córdoba, 14010 Córdoba, Spain; [email protected] (A.G.-F.); [email protected] (M.J.d.l.T.-A.); [email protected] (K.F.-R.); [email protected] (M.G.-C.) 5 CIBEROBN (CIBER Physiopathology of Obesity and Nutrition), Instituto de Salud Carlos III, 28029 Madrid, Spain 6 Department of Child and Adolescent Clinical Psychiatry and Psychology, Reina Sofia University Hospital, Maimónides Institute for Biomedical Research of Córdoba (IMIBIC), 14010 Cordoba, Spain;
    [Show full text]
  • Functional Comparison of Bacteria from the Human Gut and Closely
    Functional comparison of bacteria from the human gut and closely related non-gut bacteria reveals the importance of conjugation and a paucity of motility and chemotaxis functions in the gut environment Dragana Dobrijevic, Anne-Laure Abraham, Alexandre Jamet, Emmanuelle Maguin, Maarten van de Guchte To cite this version: Dragana Dobrijevic, Anne-Laure Abraham, Alexandre Jamet, Emmanuelle Maguin, Maarten van de Guchte. Functional comparison of bacteria from the human gut and closely related non-gut bacte- ria reveals the importance of conjugation and a paucity of motility and chemotaxis functions in the gut environment. PLoS ONE, Public Library of Science, 2016, 11 (7), pp.e0159030. 10.1371/jour- nal.pone.0159030. hal-01353535 HAL Id: hal-01353535 https://hal.archives-ouvertes.fr/hal-01353535 Submitted on 11 Aug 2016 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not. The documents may come from émanant des établissements d’enseignement et de teaching and research institutions in France or recherche français ou étrangers, des laboratoires abroad, or from public or private research centers. publics ou privés. Distributed under a Creative Commons Attribution| 4.0 International License RESEARCH ARTICLE Functional Comparison of Bacteria from the Human Gut and Closely Related Non-Gut Bacteria Reveals
    [Show full text]
  • Transcriptional Interactions Suggest Niche Segregation Among
    LETTERS PUBLISHED: 26 AUGUST 2016 | ARTICLE NUMBER: 16152 | DOI: 10.1038/NMICROBIOL.2016.152 Transcriptional interactions suggest niche segregation among microorganisms in the human gut Damian Rafal Plichta1,2, Agnieszka Sierakowska Juncker1, Marcelo Bertalan1, Elizabeth Rettedal3, Laurent Gautier1,4, Encarna Varela5, Chaysavanh Manichanh5, Charlène Fouqueray6, Florence Levenez6,7,TrineNielsen8,JoëlDoré7,9, Ana Manuel Dantas Machado3, Mari Cristina Rodriguez de Evgrafov3, Torben Hansen8,10, Torben Jørgensen11,12,13, Peer Bork14, Francisco Guarner5, Oluf Pedersen8,11, Metagenomics of the Human Intestinal Tract (MetaHIT) Consortium†,MortenO.A.Sommer3,S.DuskoEhrlich7,9,15, Thomas Sicheritz-Pontén1, Søren Brunak1,16* and H. Bjørn Nielsen1,2* The human gastrointestinal (GI) tract is the habitat for fermentation of complex substrates11 and exchange of metabolites12, hundreds of microbial species, of which many cannot be culti- and antagonistic interactions that include competition for resources13 vated readily, presumably because of the dependencies or adhesion sites14 and the production of antimicrobial compounds15. between species1. Studies of microbial co-occurrence in the At the community level, microbes with shared genetic potential tend gut have indicated community substructures that may reflect to coexist in the human GI tract, which suggests that the microbiome functional and metabolic interactions between cohabiting ensemble is driven by habitat filtering4. Classic population ecology species2,3. To move beyond species co-occurrence networks, theory, however, predicts that competition between two undifferen- we systematically identified transcriptional interactions tiated species eventually will lead to the extinction of one of them16, between pairs of coexisting gut microbes using metagenomics which raises the question of how microbes with overlapping and microarray-based metatranscriptomics data from 233 stool functional potential differentiate in the human GI tract.
    [Show full text]